Buy Now
Chronic Wound Care Market Size, Share, Growth & Industry Analysis, By Type (Diabetic Ulcers, Pressure Ulcers, Others), By Product (Advanced Wound Dressings, Wound Care Therapy, Active Therapy, Others), By End-User (Hospitals & Wound Care Centers, Homecare Settings, Others) and Regional Analysis, 2023-2030
Pages: 120 | Base Year: 2022 | Release: June 2023 | Author: Ashim L.
The global Chronic Wound Care Market size was valued at USD 11.17 billion in 2022 and is projected to reach USD 15.51 billion by 2030, growing at a CAGR of 4.28% from 2023 to 2030. In the scope of work, the report includes products offered by companies such as 3M, Braun SE, Cardinal Health, Coloplast A/S, Colzyx AB, Convatec Inc., Integra LifeSciences, Kane Biotech Inc., Medline Industries, Inc., Smith+Nephew and Others.
The need for chronic wound care is rising rapidly owing to the increasing number of chronic cases due to an aging population and an increase in the prevalence of diabetes and obesity. However, the treatment of burn injuries remains a major challenge in wound care. Many advanced techniques are available to support chronic wound healing that can stimulate tissue regeneration which usually comes from harvested natural tissues.
However, the complications and high costs associated with the product restrict the chronic wound care market growth. In addition to the high costs associated with evidence-based wound care, it is difficult for patients to access professional wound care and management. As research in this field continues to expand, new strategies and treatments are emerging to improve wound healing and reduce healthcare costs.
The chronic wound care market share is growing at a rapid pace owing to the availability of effective treatment of chronic wounds requires a multi-disciplinary approach that has attention increased towards prevention, early detection, and timely intervention of wounds. Recently, a focus on wound care research has been in progress which has accelerated the need for advanced wound dressings.
The World Health Organization (WHO) has considered chronic wounds as a major global problem and recommends improvements in chronic wound care, through initiatives such as increasing awareness about wound care, addressing socioeconomic and cultural factors, and investing in wound care and treatment research. Several nanotechnologies have been developed with unique properties that address specific problems related to wound care mechanisms that foster market growth.
The main objective of wound care is to promote healing and prevent infection, which is achieved through various processes such as dressings and local or systemic treatment of the wound. Patients can often achieve faster and more complete wound closure by appropriate treatment and addressing medical conditions that may affect wound healing. This, in turn, can improve quality of life, reduce pain and discomfort, and reduce the risk of complications such as infections. By effectively treating chronic wounds and preventing infections, healthcare providers can help reduce the overall cost of treating these patients.
Chronic wounds are most commonly caused by endogenous mechanisms as a result of a predisposing disease that affects dermal and epidermal tissue integrity. Chronic wounds such as leg ulcers, foot ulcers, and pressure sores may develop as a result of poor arterial supply or poor venous drainage, as well as metabolic illnesses such as diabetes mellitus. Chronic wound care can provide significant benefits to patients who suffer from wounds that do not heal in time and effective wound care requires a multidisciplinary approach that includes a combination of medical, surgical, and therapeutic interventions.
The demand for chronic wound care has increased in recent years due to an aging population, and an increase in chronic diseases such as diabetes & cardiovascular disease. According to the International Diabetes Federation (IDF), in 2021, diabetes affected around 537 million persons aged 20 to 79. The total number of diabetics is expected to reach 643 million by 2030 and 783 million by 2045.
This is creating demand for chronic injury services, which is rapidly increasing due to an aging population and an increase in chronic diseases globally. Effective wound care can bring significant benefits to patients, including faster healing, and improved patient satisfaction and outcomes.
The demand for chronic wound care is also influenced by factors such as healthcare infrastructure, healthcare policies, and reimbursement systems. In some countries, access to wound care services can be limited due to geographic or economic barriers, while in others there may be a shortage of health professionals with specialized knowledge and skills in wound care.
In addition, changes in healthcare policies and reimbursement systems are significantly propelling the need for chronic wound care services. Although the continued research & development of wound healing strategies and therapies offer a desire for continued progress in this indispensable sector of health care.
The global market is segmented based on type, product, end-user, and geography.
Based on the type, the chronic wound care market is divided into diabetic ulcers, pressure ulcers, venous ulcers, and others. The diabetic ulcer is the most dominating segment with a market value of USD 4.33 billion in 2022. This is due to the increasing number of diabetic patients worldwide with related ulcers and the availability of technologically advanced wound care products.
Based on product, the market is classified into advanced wound dressings, wound care therapy, active therapy, and others. Advanced wound dressings dominated the chronic wound care market share with a value of USD 6.12 billion in 2022. The segment growth is driven by the availability of smart wound care facilities and the growing use of artificial intelligence. The development of smart bandages is also aiding with different kinds of wounds at a low cost.
Based on end-user, the market is categorized into hospitals & wound care centers, homecare settings, and others. The homecare setting segment is expected to grow to USD 5.65 billion during the forecast period. Wound care in home care began primarily with the introduction of single-use negative pressure wound therapy (NPWT) systems. These devices are light, portable, and easy to use and are cost-effective which encourages patients to adopt home care settings.
Based on regional analysis, the global market is classified into North America, Europe, Asia Pacific, MEA, and Latin America.
The North America Chronic Wound Care Market share stood around 43.24% in 2022 in the global market, with a valuation of USD 4.83 billion. The population explosion across the region has increased the focus of healthcare providers on treating wounds such as diabetic foot and chronic venous leg ulcers. In patients with diabetic foot ulcers, this can lead to more serious consequences, such as foot amputation.
The availability of advanced chronic wound care products especially for treating critical cases of patients across the region has accelerated the chronic wound care market revenue.
The Asia Pacific is the fastest-growing region with a CAGR of 5.33% in 2022. The regional growth of the market is supported by the growing incidence of chronic diseases such as diabetes and cardiovascular disease has increased which requires effective wound care. In addition, the proliferating need to help prevent infections and improve healing rates is ultimately leading to better patient outcomes and lower healthcare costs.
The World Health Organization has identified wound care as a priority area and there are organizations dedicated to improving access to wound care services and building wound care infrastructure in countries in the region. Several emerging strategies such as telemedicine and remote monitoring of wound care offer promising solutions to some of the infrastructure challenges facing patients in peripheral areas.
Healthcare providers and policymakers are working together to address the unique challenges of providing injury services in this region, including infrastructure challenges, differences in health policies, and language and cultural barriers. The researchers across the region focus on developing nanotechnology-based therapeutic agents and evaluate the efficacy of each treatment in vivo diabetic models of chronic wound healing which propels the chronic wound care market growth across the region.
The chronic wound care market report will provide valuable insight with an emphasis on the global market and the market is highly fragmented. Major players are focusing on a few of the strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their respective market shares across different regions. Expansion & investments involve investments in R&D, new manufacturing facilities, and supply chain optimization.
Key Industry Developments
By Type
By Product
By End-User
By Region